PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Novavax, Inc., Gaithersburg, Maryland, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pmed.1003769
?:doi
?:hasPublicationType
?:journal
  • PLoS medicine
is ?:pmid of
?:pmid
?:pmid
  • 34597298
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.914
?:rankingScore_hIndex
  • 184
?:title
  • Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all